Literature DB >> 3807257

[Increase in liver circulation with nifedipine].

J Nitsch, R Kuhnen, B Lüderitz.   

Abstract

The hepatic hemodynamic effect of 20 mg sublingual nifedipine was evaluated in 15 patients (13 men, 2 women) during heart catheterization. The liver blood flow was measured 10 min after administration of nifedipine by continuous thermodilution (Baim coronary sinus flow analyzer). Nifedipine was associated with a decrease in systolic blood pressure (from 156 +/- 14 to 138 +/-13 mmHg), an increase in heart rate (from 73 +/- 13 to 81 +/- 8.6 beats/min), and increase in cardiac output (from 6.0 +/- 1.6 to 6.5 +/- 1.3 l/min). In 2/15 patients no significant change was derived. The liver blood flow increased in 13/15 patients from 218 +/- 171.7 to 336.7 +/- 247.7 ml/min (22%-194%, P less than 0.01). The study demonstrates that the vasodilation of nifedipine involves the hepatic circulation. If the hepatic clearance of drugs is high and flow dependent, nifedipine-induced increase of hepatic blood flow may impair drug clearance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3807257     DOI: 10.1007/bf01726871

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  25 in total

1.  The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction.

Authors:  R A Branch; D G Shand; G R Wilkinson; A S Nies
Journal:  J Pharmacol Exp Ther       Date:  1973-02       Impact factor: 4.030

Review 2.  [Effect of liver diseases on bioavailability and clearance of drugs].

Authors:  G Paumgartner
Journal:  Internist (Berl)       Date:  1980-12       Impact factor: 0.743

3.  Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.

Authors:  M A Creager; K M Pariser; E M Winston; H M Rasmussen; K B Miller; J D Coffman
Journal:  Am Heart J       Date:  1984-08       Impact factor: 4.749

4.  Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.

Authors:  C D Smith; R J McKendry
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

5.  Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins.

Authors:  E Mikkelsen; K E Andersson; O Lederballe Pedersen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-02

6.  Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.

Authors:  U Elkayam; L Weber; V M Campese; S G Massry; S H Rahimtoola
Journal:  J Am Coll Cardiol       Date:  1984-12       Impact factor: 24.094

7.  Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.

Authors:  A B Miller; D A Conetta; T A Bass
Journal:  Am J Cardiol       Date:  1985-05-01       Impact factor: 2.778

8.  Influence of intracoronary nifedipine on left ventricular function, coronary vasomotility, and myocardial oxygen consumption.

Authors:  P W Serruys; T E Hooghoudt; J H Reiber; C Slager; R W Brower; P G Hugenholtz
Journal:  Br Heart J       Date:  1983-05

9.  Effects of nifedipine on systemic and regional oxygen transport and metabolism at rest and during exercise.

Authors:  C Y Choong; G S Roubin; W F Shen; P J Harris; D T Kelly
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

10.  Effects of nifedipine on baroreflex modulation of vascular resistance in man.

Authors:  D W Ferguson; J K Dorsey
Journal:  Am Heart J       Date:  1985-01       Impact factor: 4.749

View more
  1 in total

1.  The influence of nifedipine and captopril on liver blood flow in healthy subjects.

Authors:  J Burggraaf; R C Schoemaker; J M Kroon; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.